The document outlines the scaling efforts of the Camden Coalition of Healthcare Providers (CCHP) care management program from 2007-2012. It began with a focus on super-utilizers of the emergency department and enrolled 50 patients in the first month. Over time, CCHP expanded the program to serve hundreds more high-cost patients, created a care coordination team, and obtained additional grants to embed nurses in community health centers and provide direct outreach to patients in the hospital. The care management workflow involved identifying high-risk patients from admission data, conducting outreach and enrolling them, providing interventions like home visits and medication reconciliation, and connecting patients to primary care. CCHP also focused on workforce development and establishing protocols
Speaker Presentation from U.S. News Healthcare of Tomorrow leadership summit, November 2-4, 2016 in Washington, DC. Find out more about this forum at www.usnewshot.com.
Stepping up Pediatric Patient Safety (Chris Dickinson)Ashleigh Kades
Speaker Presentation from U.S. News Healthcare of Tomorrow leadership summit, November 2-4, 2016 in Washington, DC. Find out more about this forum at www.usnewshot.com.
Implementing a Population Health Model (Timothy Ferris)Ashleigh Kades
Speaker Presentation from U.S. News Healthcare of Tomorrow leadership summit, November 2-4, 2016 in Washington, DC. Find out more about this forum at www.usnewshot.com.
Speaker Presentation from U.S. News Healthcare of Tomorrow leadership summit, November 2-4, 2016 in Washington, DC. Find out more about this forum at www.usnewshot.com.
Stepping up Pediatric Patient Safety (Meri Armour)Ashleigh Kades
Speaker Presentation from U.S. News Healthcare of Tomorrow leadership summit, November 2-4, 2016 in Washington, DC. Find out more about this forum at www.usnewshot.com.
Hitting the Sweet Spot with Predictive Analytics (Michael Draugelis)Ashleigh Kades
Speaker Presentation from U.S. News Healthcare of Tomorrow leadership summit, November 2-4, 2016 in Washington, DC. Find out more about this forum at www.usnewshot.com.
Keeping the Pediatric Population Healthy (David Bailey)Ashleigh Kades
Speaker Presentation from U.S. News Healthcare of Tomorrow leadership summit, November 2-4, 2016 in Washington, DC. Find out more about this forum at www.usnewshot.com.
Speaker Presentation from U.S. News Healthcare of Tomorrow leadership summit, November 2-4, 2016 in Washington, DC. Find out more about this forum at www.usnewshot.com.
Stepping up Pediatric Patient Safety (Chris Dickinson)Ashleigh Kades
Speaker Presentation from U.S. News Healthcare of Tomorrow leadership summit, November 2-4, 2016 in Washington, DC. Find out more about this forum at www.usnewshot.com.
Implementing a Population Health Model (Timothy Ferris)Ashleigh Kades
Speaker Presentation from U.S. News Healthcare of Tomorrow leadership summit, November 2-4, 2016 in Washington, DC. Find out more about this forum at www.usnewshot.com.
Speaker Presentation from U.S. News Healthcare of Tomorrow leadership summit, November 2-4, 2016 in Washington, DC. Find out more about this forum at www.usnewshot.com.
Stepping up Pediatric Patient Safety (Meri Armour)Ashleigh Kades
Speaker Presentation from U.S. News Healthcare of Tomorrow leadership summit, November 2-4, 2016 in Washington, DC. Find out more about this forum at www.usnewshot.com.
Hitting the Sweet Spot with Predictive Analytics (Michael Draugelis)Ashleigh Kades
Speaker Presentation from U.S. News Healthcare of Tomorrow leadership summit, November 2-4, 2016 in Washington, DC. Find out more about this forum at www.usnewshot.com.
Keeping the Pediatric Population Healthy (David Bailey)Ashleigh Kades
Speaker Presentation from U.S. News Healthcare of Tomorrow leadership summit, November 2-4, 2016 in Washington, DC. Find out more about this forum at www.usnewshot.com.
Presentation given by Liz Mearns, Regional Medical Director (Wessex), NHS England. At the Improving access to sene day services event, Southampton 25 March 2015
ACOs and vanguards: Reflections from the USA - Mark LeenayNuffield Trust
Mark Leenay from Optum in the US presents to the Nuffield Trust health policy summit on accountable care organisations and what lessons they may have for vanguards in the UK.
Speaker Presentation from U.S. News Healthcare of Tomorrow leadership summit, November 2-4, 2016 in Washington, DC. Find out more about this forum at www.usnewshot.com.
Speaker Presentation from U.S. News Healthcare of Tomorrow leadership summit, November 2-4, 2016 in Washington, DC. Find out more about this forum at www.usnewshot.com.
Increased attention to children with medical complexity has occurred because these children are growing in number, consume a disproportionate share of health-system costs, and require policy and programmatic interventions that differ in many ways from the broader group of children with special health care needs. But will this focus on complex care lead to meaningful changes in systems of care and outcomes for children with serious chronic diseases?
Shelia R. Cotten, PhD Director, Sparrow/MSU Center for Innovation and Research Director, Trifecta Professor and Associate Chair for Research, Department of Media & Information Michigan State University cotten@msu.edu
9/17/2015
For the Nuffield Trust Health Policy Summit, Stephen Shortt tells the story of a journey from multiple unconnected practices to accountable community based integrated services at scale.
The perfect health system - Dr Mark BritnellNuffield Trust
At the first keynote for the Nuffield Trust Health Policy Summit 2016, Mark Britnell gives an overview of key characteristics of effective health systems.
OpenAthens Conference 2019: Clinician training in the Queensland public healt...OpenAthens
Cindy Slater, senior customer engagement manager, EBSCO.
The session provides an insight into how training is delivered to clinicians in Queensland Health and touch on challenges associated with ensuring all staff across this large geographic area have access to the resources, know how to access the resources, and how to get the most out resources.
Keynote Presentation delivered by Marvin O’Quinn, Executive Vice President and Chief Operating Officer, Dignity Health at the marcus evans National Healthcare CXO Summit Spring 2018 held in Orlando FL
Presentation given by Liz Mearns, Regional Medical Director (Wessex), NHS England. At the Improving access to sene day services event, Southampton 25 March 2015
ACOs and vanguards: Reflections from the USA - Mark LeenayNuffield Trust
Mark Leenay from Optum in the US presents to the Nuffield Trust health policy summit on accountable care organisations and what lessons they may have for vanguards in the UK.
Speaker Presentation from U.S. News Healthcare of Tomorrow leadership summit, November 2-4, 2016 in Washington, DC. Find out more about this forum at www.usnewshot.com.
Speaker Presentation from U.S. News Healthcare of Tomorrow leadership summit, November 2-4, 2016 in Washington, DC. Find out more about this forum at www.usnewshot.com.
Increased attention to children with medical complexity has occurred because these children are growing in number, consume a disproportionate share of health-system costs, and require policy and programmatic interventions that differ in many ways from the broader group of children with special health care needs. But will this focus on complex care lead to meaningful changes in systems of care and outcomes for children with serious chronic diseases?
Shelia R. Cotten, PhD Director, Sparrow/MSU Center for Innovation and Research Director, Trifecta Professor and Associate Chair for Research, Department of Media & Information Michigan State University cotten@msu.edu
9/17/2015
For the Nuffield Trust Health Policy Summit, Stephen Shortt tells the story of a journey from multiple unconnected practices to accountable community based integrated services at scale.
The perfect health system - Dr Mark BritnellNuffield Trust
At the first keynote for the Nuffield Trust Health Policy Summit 2016, Mark Britnell gives an overview of key characteristics of effective health systems.
OpenAthens Conference 2019: Clinician training in the Queensland public healt...OpenAthens
Cindy Slater, senior customer engagement manager, EBSCO.
The session provides an insight into how training is delivered to clinicians in Queensland Health and touch on challenges associated with ensuring all staff across this large geographic area have access to the resources, know how to access the resources, and how to get the most out resources.
Keynote Presentation delivered by Marvin O’Quinn, Executive Vice President and Chief Operating Officer, Dignity Health at the marcus evans National Healthcare CXO Summit Spring 2018 held in Orlando FL
Our presentation at AMIA about our regional MRSA collaborative and use of health information technology to share MRSA colonization and infection data electronically.
Presentation delivered by Steve Neorr, Chief Administrative Officer, Triad HealthCare Network at the marcus evans National Healthcare CXO Summit 2018 in Orlando FL
Pharmacy's Emerging Role in Accountable Care Organizations (ACO)Parata Systems
Your pharmacy is an excellent partner for accountable care organizations. ACOs are formed by doctors, hospitals and other healthcare providers to improve health outcomes and lower overall medical expenses for a targeted patient population. Reimbursements are tied to patient outcomes.
ACOs’ highest-risk and highest-cost patients are those managing chronic illnesses and taking multiple medications a day. When your pharmacy can improve and track adherence – a key driver of readmission prevention and overall health – you are a valuable partner to help ACOs prevent unnecessary medical care.
Jamie Hale serves as the Chief Pharmacy Officer for Cornerstone Health Care where he is responsible for the development and integration of pharmaceutical care services in the Accountable Care Organization. He transitioned to Cornerstone in December 2012 after a 15 year career at Wake Forest Baptist Health, where he last served as Director of Pharmacy.
Download the full audio webinar at http://bit.ly/pharmacyACO.
Jacquie White, Deputy Director of NHS England Long Term Conditions, Older People & End of Life Care and Dr Eileen Pepler, Academic, Researcher and Consultant in the Canadian Healthcare will discuss how NHS England work in chronic disease is being translated into a Canadian context.
The Patient-Centered Medical Home Impact on Cost and Quality: An Annual Revie...CHC Connecticut
Dr. Nwando Olayiwola, Associate Director, Center for Excellence in Primary Care, Assistant Professor, University of California, San Francisco addresses the 2014 Weitzman Symposium on The Patient-Centered Medical Home Impact on Cost and Quality: An Annual Review of Evidence
Pam Creaven - Bringing integrated care to lifeAge UK
Pam Creaven, Services Director, Age UK - presentation from Age UK For Later Life conference, 25th April.
For more information: www.ageuk.org.uk/forlaterlife
What Does Commissioning and Quality Improvement Mean to Me?Sarah Amani
This was a good question which got me thinking: there are so many buzz words in healthcare sometimes its good to unpack what we mean. As one of the areas I cover, Cornwall and the Isles of Scilly are of huge importantance and interest to me so I was really happy to be invited to meet with their impressive commissioning and quality improvement team to discuss this topic
Key Principles and Approaches to Populaiton Health mManagement - HAS Session 21Health Catalyst
Population Health Management is in its early stages of maturity, suffering from inconsistent definitions and understanding, and is overhyped by vendors and ill-defined by the industry. And yet, many systems are moving forward in innovative pioneering ways to address this growing trend. In this session, you will hear from two very different, successful health systems: a physician-led group and a large integrated delivery system. They will share their best practices, learnings, and different approaches to population health management.
Medicaid 1115 Waiver Program
Catherine Gibson, Chief Waiver Officer
University Medical Center of El Paso
Anchor Hospital -- Region 15
Mano y Corazón Binational Conference of Multicultural Health Care Solutions, El Paso, Texas, September 27-28, 2013
The Effects of Trauma on Health Care Utilizationandreacamden
This webinar will discuss the effects of childhood trauma on health care utilization and chronic illness. Susan Lax is an Advanced Practice Nurse with a dual degree in psychiatry/mental health nursing and primary care nursing from the Institute of Health Professions at Massachusetts General Hospital. She is certified in Trauma Studies by the Trauma Center at JRI, trained by Bessel van der Kolk and his colleagues. She has completed trainings in Sensorimotor Psychotherapy, a mindfulness approach to treating trauma disorders. In all, she has completed more than 300 hours of training in the treatment of acute and developmental trauma. In 2010 Susan was awarded a leadership in nursing award for her success incorporating a trauma treatment as she worked in acute, residential, and community settings in the Greater Boston Area, including on a PACT team.
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists Saeid Safari
Preoperative Management of Patients on GLP-1 Receptor Agonists like Ozempic and Semiglutide
ASA GUIDELINE
NYSORA Guideline
2 Case Reports of Gastric Ultrasound
Title: Sense of Smell
Presenter: Dr. Faiza, Assistant Professor of Physiology
Qualifications:
MBBS (Best Graduate, AIMC Lahore)
FCPS Physiology
ICMT, CHPE, DHPE (STMU)
MPH (GC University, Faisalabad)
MBA (Virtual University of Pakistan)
Learning Objectives:
Describe the primary categories of smells and the concept of odor blindness.
Explain the structure and location of the olfactory membrane and mucosa, including the types and roles of cells involved in olfaction.
Describe the pathway and mechanisms of olfactory signal transmission from the olfactory receptors to the brain.
Illustrate the biochemical cascade triggered by odorant binding to olfactory receptors, including the role of G-proteins and second messengers in generating an action potential.
Identify different types of olfactory disorders such as anosmia, hyposmia, hyperosmia, and dysosmia, including their potential causes.
Key Topics:
Olfactory Genes:
3% of the human genome accounts for olfactory genes.
400 genes for odorant receptors.
Olfactory Membrane:
Located in the superior part of the nasal cavity.
Medially: Folds downward along the superior septum.
Laterally: Folds over the superior turbinate and upper surface of the middle turbinate.
Total surface area: 5-10 square centimeters.
Olfactory Mucosa:
Olfactory Cells: Bipolar nerve cells derived from the CNS (100 million), with 4-25 olfactory cilia per cell.
Sustentacular Cells: Produce mucus and maintain ionic and molecular environment.
Basal Cells: Replace worn-out olfactory cells with an average lifespan of 1-2 months.
Bowman’s Gland: Secretes mucus.
Stimulation of Olfactory Cells:
Odorant dissolves in mucus and attaches to receptors on olfactory cilia.
Involves a cascade effect through G-proteins and second messengers, leading to depolarization and action potential generation in the olfactory nerve.
Quality of a Good Odorant:
Small (3-20 Carbon atoms), volatile, water-soluble, and lipid-soluble.
Facilitated by odorant-binding proteins in mucus.
Membrane Potential and Action Potential:
Resting membrane potential: -55mV.
Action potential frequency in the olfactory nerve increases with odorant strength.
Adaptation Towards the Sense of Smell:
Rapid adaptation within the first second, with further slow adaptation.
Psychological adaptation greater than receptor adaptation, involving feedback inhibition from the central nervous system.
Primary Sensations of Smell:
Camphoraceous, Musky, Floral, Pepperminty, Ethereal, Pungent, Putrid.
Odor Detection Threshold:
Examples: Hydrogen sulfide (0.0005 ppm), Methyl-mercaptan (0.002 ppm).
Some toxic substances are odorless at lethal concentrations.
Characteristics of Smell:
Odor blindness for single substances due to lack of appropriate receptor protein.
Behavioral and emotional influences of smell.
Transmission of Olfactory Signals:
From olfactory cells to glomeruli in the olfactory bulb, involving lateral inhibition.
Primitive, less old, and new olfactory systems with different path
micro teaching on communication m.sc nursing.pdfAnurag Sharma
Microteaching is a unique model of practice teaching. It is a viable instrument for the. desired change in the teaching behavior or the behavior potential which, in specified types of real. classroom situations, tends to facilitate the achievement of specified types of objectives.
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...i3 Health
i3 Health is pleased to make the speaker slides from this activity available for use as a non-accredited self-study or teaching resource.
This slide deck presented by Dr. Kami Maddocks, Professor-Clinical in the Division of Hematology and
Associate Division Director for Ambulatory Operations
The Ohio State University Comprehensive Cancer Center, will provide insight into new directions in targeted therapeutic approaches for older adults with mantle cell lymphoma.
STATEMENT OF NEED
Mantle cell lymphoma (MCL) is a rare, aggressive B-cell non-Hodgkin lymphoma (NHL) accounting for 5% to 7% of all lymphomas. Its prognosis ranges from indolent disease that does not require treatment for years to very aggressive disease, which is associated with poor survival (Silkenstedt et al, 2021). Typically, MCL is diagnosed at advanced stage and in older patients who cannot tolerate intensive therapy (NCCN, 2022). Although recent advances have slightly increased remission rates, recurrence and relapse remain very common, leading to a median overall survival between 3 and 6 years (LLS, 2021). Though there are several effective options, progress is still needed towards establishing an accepted frontline approach for MCL (Castellino et al, 2022). Treatment selection and management of MCL are complicated by the heterogeneity of prognosis, advanced age and comorbidities of patients, and lack of an established standard approach for treatment, making it vital that clinicians be familiar with the latest research and advances in this area. In this activity chaired by Michael Wang, MD, Professor in the Department of Lymphoma & Myeloma at MD Anderson Cancer Center, expert faculty will discuss prognostic factors informing treatment, the promising results of recent trials in new therapeutic approaches, and the implications of treatment resistance in therapeutic selection for MCL.
Target Audience
Hematology/oncology fellows, attending faculty, and other health care professionals involved in the treatment of patients with mantle cell lymphoma (MCL).
Learning Objectives
1.) Identify clinical and biological prognostic factors that can guide treatment decision making for older adults with MCL
2.) Evaluate emerging data on targeted therapeutic approaches for treatment-naive and relapsed/refractory MCL and their applicability to older adults
3.) Assess mechanisms of resistance to targeted therapies for MCL and their implications for treatment selection
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?bkling
Are you curious about what’s new in cervical cancer research or unsure what the findings mean? Join Dr. Emily Ko, a gynecologic oncologist at Penn Medicine, to learn about the latest updates from the Society of Gynecologic Oncology (SGO) 2024 Annual Meeting on Women’s Cancer. Dr. Ko will discuss what the research presented at the conference means for you and answer your questions about the new developments.
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...kevinkariuki227
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Verified Chapters 1 - 19, Complete Newest Version.pdf
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Verified Chapters 1 - 19, Complete Newest Version.pdf
New Drug Discovery and Development .....NEHA GUPTA
The "New Drug Discovery and Development" process involves the identification, design, testing, and manufacturing of novel pharmaceutical compounds with the aim of introducing new and improved treatments for various medical conditions. This comprehensive endeavor encompasses various stages, including target identification, preclinical studies, clinical trials, regulatory approval, and post-market surveillance. It involves multidisciplinary collaboration among scientists, researchers, clinicians, regulatory experts, and pharmaceutical companies to bring innovative therapies to market and address unmet medical needs.
Couples presenting to the infertility clinic- Do they really have infertility...Sujoy Dasgupta
Dr Sujoy Dasgupta presented the study on "Couples presenting to the infertility clinic- Do they really have infertility? – The unexplored stories of non-consummation" in the 13th Congress of the Asia Pacific Initiative on Reproduction (ASPIRE 2024) at Manila on 24 May, 2024.
Acute scrotum is a general term referring to an emergency condition affecting the contents or the wall of the scrotum.
There are a number of conditions that present acutely, predominantly with pain and/or swelling
A careful and detailed history and examination, and in some cases, investigations allow differentiation between these diagnoses. A prompt diagnosis is essential as the patient may require urgent surgical intervention
Testicular torsion refers to twisting of the spermatic cord, causing ischaemia of the testicle.
Testicular torsion results from inadequate fixation of the testis to the tunica vaginalis producing ischemia from reduced arterial inflow and venous outflow obstruction.
The prevalence of testicular torsion in adult patients hospitalized with acute scrotal pain is approximately 25 to 50 percent
Ethanol (CH3CH2OH), or beverage alcohol, is a two-carbon alcohol
that is rapidly distributed in the body and brain. Ethanol alters many
neurochemical systems and has rewarding and addictive properties. It
is the oldest recreational drug and likely contributes to more morbidity,
mortality, and public health costs than all illicit drugs combined. The
5th edition of the Diagnostic and Statistical Manual of Mental Disorders
(DSM-5) integrates alcohol abuse and alcohol dependence into a single
disorder called alcohol use disorder (AUD), with mild, moderate,
and severe subclassifications (American Psychiatric Association, 2013).
In the DSM-5, all types of substance abuse and dependence have been
combined into a single substance use disorder (SUD) on a continuum
from mild to severe. A diagnosis of AUD requires that at least two of
the 11 DSM-5 behaviors be present within a 12-month period (mild
AUD: 2–3 criteria; moderate AUD: 4–5 criteria; severe AUD: 6–11 criteria).
The four main behavioral effects of AUD are impaired control over
drinking, negative social consequences, risky use, and altered physiological
effects (tolerance, withdrawal). This chapter presents an overview
of the prevalence and harmful consequences of AUD in the U.S.,
the systemic nature of the disease, neurocircuitry and stages of AUD,
comorbidities, fetal alcohol spectrum disorders, genetic risk factors, and
pharmacotherapies for AUD.
1. Camden Coalition of
Healthcare Providers
Scaling: Where to Begin?
July 31, 2013
Camden Coalition of
Healthcare Providers
www.camdenhealth.org
2. 2007
• New Jersey Health Initiatives funding
for 3 years
– Primary focus: ED “super-utilizers”
– Enroll 50 patients the first month
“once the details of the protocol are
finalized”
– 400 by the end of the 1st year, 600 by the
end of the 3rd year
“…remain in the intervention until their
needs have been met”
www.camdenhealth.org
3. • Developed CCHP Care Management
Team
– Served approx. 300 patients
• Created citywide care coordination
meeting
• Created infrastructure for citywide
health information exchange
www.camdenhealth.org
4. 2011
• NJHI-Care Transitions grant
– 400 high cost patients over 2 years
– 25% tier 1
– 75% tier 2
– Embed nurse care coordinators in local
FQHCs
www.camdenhealth.org
5. • Created 90 day workflow that directly
outreach to patients in the hospital
– Focus on inpatient admissions
• Daily data feed of Camden residents
with high hospital utilization
• RN led model
• High risk vs. low risk—no difference
www.camdenhealth.org
6. ED visits, 2011
Inpatient visits, 2011
0 1 2 3 to 4 5+
0
44,728 (85%) patients
5,210 Inpatient visits
63,489 ED visits
$28,000,000 (50%) IP payment
$25,800,000 (59%) ED payment
985 (2%) patients
1,856 IP visits
4,129 ED visits
$10,000,000 (17%) IP
payment
$1,700,000 (4%) ED
payments
503 (1%) patients
2,026 Inpatient Visits
4,144 ED Visits
$10,900,000 (20%) in IP payment
$1,700,000 (4%)in ED payment
1
2 to 3
4 to 5
4,961(9%) patients
28,447 ED visits
$11,500,000 (27%) in
ED payment
1,563 (3%) patients
1,239 IP visits
6,962 ED visits
$6,700,000 (18%) in IP
payment
$2,800,000 (6%) in ED
payment
6 to 7
8 to 9
10 +
6www.camdenhealth.org
Camden Hospital Utilization Typology
Understand
the
problem
7. 2012
• CMMI/Health Care Innovation Award
– Awarded approx. $3 million
– Generate $6 million in savings
– Serve over 800 patients over 3 years
www.camdenhealth.org
8. APN SW CHWPMStart up
Staff Composition
RN
LPN
LPN
CHW
HC
HC
Pr. Dir.
SW
Outreach
Specialist
www.camdenhealth.org
10. Care Management Workflow
•Admissions
data
•Current day
•Access to
patient chart
Data
•Assessment
•Assignment
Triage
•Blend of
medical &
social
complexity
Outreach
•Completion
of care plan
•Transition to
PCP
Graduation
Patients Flagged:
• 2+ hospital
admissions < 6
months
Selection Criteria:
• History of chronic
disease related
admits
• Rule out criteria
• Validate risk score
• Assigned to
outreach team
Intervention:
• Bedside
outreach/enrollment
• Home visit w/in 48
hrs of d/c
• PCP w/in 7 days
• Front load nursing
outreach, followed
by social outreach
Discharge
• Deceased
• Moved
• Lost contact
• Disengaged
www.camdenhealth.org
11. Guiding Principles
• Enroll patients based on data; history of
repeat admissions (high cost) and specific
inclusion criteria
• Provide immediate and intensive follow-up
coordination post discharge; connect patient
to PCP as quickly as possible (target = 7 days
post d/c)
• Dramatically improve the relationship between
patient/family and PCP & specialists
• Equal focus of intervention on coaching
www.camdenhealth.org